Immuno-Biological Laboratories
Gumma
About Immuno-Biological Laboratories
Immuno-Biological Laboratories is a research, develop, manufacture, and supply various immunological research reagents, and customized services. Immuno-Biological Laboratories is a research and development on the materials used in diagnostic products and valuable seeds in their existing portfolio, and aim to obtain approval for their use in in-vitro diagnostic products and drugs. Immuno-Biological Laboratories is a research and development on state-of-the-art technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $12.2M
- Funding stage: IPO
- Last round: Post-IPO Debt (Dec 2016)
- Ticker: tyo:4570
- Website: ibl-japan.co.jpen
- Phone: +81274222889
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/immuno-biological-laboratories-2229960 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.